About Us

Treatobacco.net is for those working on the treatment of tobacco dependence throughout the world. It presents authoritative (see Contributors), independent (see Funders), evidence-based information about the treatment of tobacco dependence, under five headings: Demographics and Health Effects, Efficacy, Health Economics, Policy, Safety.

Key findings, commentaries and supporting references have been collated and reviewed by around 50 international experts and the evidence is periodically updated to incorporate new research. Referenced slide kits and other resources can also be downloaded from the site.

Treatobacco.net is run by the Society for Research on Nicotine and Tobacco (SRNT) in partnership with the Society for the Study of Addiction (SSA), the InterAmerican Heart Foundation (IAHF) and the National Centre for Smoking Cessation and Training (NCSCT). The core content of treatobacco.net is currently available in 11 languages making it a genuinely international resource for those interested in treating tobacco dependence around the world. The languages are: Arabic, Chinese, Czech, English, French, German, Italian, Japanese, Portuguese, Russian, and Spanish.

Treatobacco.net is a unique source of evidence-based data and practical support for the treatment of tobacco dependence. It is aimed at physicians, nurses, pharmacists, dentists, psychologists, researchers, policy makers, regulators and anyone interested in the personal and public health issues connected with tobacco use around the world.

The treatment of tobacco dependence is a popular subject for research and finding evidence-based, authoritative data can be time-consuming. Treatobacco.net was developed to bring the best information together in a single, independent website.

Funders

Current funders

In 2010 the treatobacco.net Board took the decision no longer to accept financial support from the pharmaceutical industry. Treatobacco.net is currently funded by the Society for the Study of Addiction, the American Cancer Society, the National Centre for Smoking Cessation and Training, and the Society for Research on Nicotine and Tobacco.

Funding history

Since its creation in 2000 treatobacco.net was supported by the American Cancer Society (ACS), French Cancer League, GlaxoSmithKline, Johnson & Johnson, National Cancer Institute, France (INCa), National Cancer Institute, US (NCI), National Institute on Drug Abuse (NIDA), Pfizer, Robert Wood Johnson Foundation, the Roswell Park Transdisciplinary Tobacco Use Research Center, and the Society for the Study of Addiction to Alcohol and Other Drugs, to whom we are extremely grateful. No funders with a direct competing interest sat on the management board.

Structure and management arrangements

Treatobacco.net is run by a management board chaired by Dorothy Hatsukami on behalf of SRNT. The board includes representatives from Africa, China, India and Latin America. Financial administration is based at SRNT and the project administrator at Nottingham University, England. Each of the five core sections has a chair assisted by a group of experts. The editorial board has a chair, a deputy chair, and currently 9 members. Ten tobacco specialists check the translations from English, which were originally made by a translation agency. Contributors include scientists from the Cochrane Centre, Centers for Disease Control, American Cancer Society, and many universities.

Treatobacco is an authoritative, independent resource with global reach.

A new website

Treatobacco.net has undergone a major update culminating in its relaunch at the SRNT Annual meeting in February 2008, and the site has been completely redesigned. We will now be adding new content continuously, and so will be able to offer topical material (for example conference announcements) as well as a greater range of material, and we will use the site to keep you updated on progress on Article 14 of the FCTC. We welcome feedback on all aspects of the site, especially to help us build a resource library that will help you in your work.

Society for Research on Nicotine and Tobacco

SRNT is the only international scientific society entirely dedicated to fostering and disseminating research on tobacco and nicotine. SRNT has over 1,000 members in 40 countries, 899 in North America, 95 in Europe and 52 in the rest of the world. SRNT's annual conference brings together the world's greatest concentration of research scientists and research findings on nicotine and tobacco. SRNT has a long history of providing scientific expertise and information to the World Health Organization, the United Kingdom's Health Education Authority, the US Food and Drug Administration and other national and international bodies.

Contributors

Management team

Jacques Le Houezec, Manager
Freelance consultant, Rennes, France; Special Lecturer, UK Centre for Tobacco Control Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.

Martin Raw, Deputy Manager
Freelance consultant; Special Lecturer, UK Centre for Tobacco Control Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.

Ann McNeill, Management Advisor
Professor of Addictions, UK Centre for Tobacco Control Studies, National Addiction Centre, Institute of Psychiatry, King's College London, UK.

Marilyn Antoniak, Administrator
UK Centre for Tobacco Control Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.

Management board

Dorothy Hatsukami, Chair
Society for Research on Nicotine and Tobacco; Director, Tobacco Use Research Center, Department of Psychiatry, University of Minnesota, Minneapolis, USA.

Thomas Glynn, Deputy Chair
Director, Cancer Science and Trends, and Director, International Cancer Control, American Cancer Society, Washington, USA.

Maxine Stitzer, Editorial Board Chair
Professor, Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, USA.

Mira Aghi
Behavioral Scientist, Freelance consultant in Health and Development, New Delhi, India.

Lekan Ayo-Yusuf
Senior Lecturer/Senior Stomatologist, Department of Community Dentistry, School of Dentistry, University of Pretoria, Pretoria, South Africa.

Eduardo Bianco
Latin American Director, Framework Convention Alliance; Director, Tobacco Control Program, InterAmerican Heart Foundation; President, Research Centre of the Tobacco Epidemic in Uruguay, Montevideo, Uruguay.

Sophia Chan
Professor and Head, Department of Nursing Studies & Deputy Director, Public Health Research Center, University of Hong Kong, Hong Kong, China.

Feras Hawari
Director, Cancer Control Office, Chief, Section of Pulmonary and Critical Care, Director, Respiratory Therapy Service, King Hussein Cancer Center, Amman, Jordan.

Natasha Herrera
Director, Smoking Cessation and Research Clinic, Centro Médico Docente la Trinidad, Caracas, Venezuela.

Harry Lando
Distinguished International Professor, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, USA.

Main sections

Demographics and Health Effects

David Homa, Chair
Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA.

Peter Anderson
Independent Consultant on Public Health, Spain.

Mary-Jane Ashley
Department of Public Health Sciences, University of Toronto, Toronto, Canada.

Shanta R Dube
Lead Health Scientist, Office on Smoking and Health, Centers for Disease Control and Prevention, Atlanta, USA.

Linda Pederson
Epidemiologist and Public Health Consultant, London, Ontario, Canada.

Jonathan Samet
Professor and Flora L Thornton Chair, Department of Preventive Medicine, Keck School of Medicine & Director, Institute for Global Health, University of Southern California, Los Angeles, USA.

Michael Thun
Vice President, Epidemiology and Surveillance Research, American Cancer Society, Atlanta, USA.

Efficacy

Lindsay Stead, Chair
The Cochrane Tobacco Addiction Group, The Cochrane Collaboration, Oxford, UK.

Paul Aveyard
UK Centre for Tobacco Control Studies, University of Birmingham, Birmingham,UK

Michael Fiore
Director of the Center for Tobacco Research and Intervention and Professor of Medicine, University of Wisconsin Medical School, University of Wisconsin, USA

Jonathan Foulds
Professor of Public Health Sciences, Penn State University, College of Medicine
Hershey, Pennsylvania, USA

John Hughes
Professor of Psychiatry, Psychology and Family Practice, University of Vermont, Burlington, USA

Martin Raw
Freelance consultant; Special Lecturer, UK Centre for Tobacco Control Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK

Robert West
Professor of Health Psychology, Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, London, UK

Health Economics

Hana Ross, Chair
Strategic Director, International Tobacco Surveillance, Epidemiology and Surveillance Research, American Cancer Society, Atlanta, USA.

Frank Chaloupka
Distinguished Professor, Department of Economics and Division of Health Policy and Administration and Director, Health Policy Center, University of Illinois, Chicago, USA.

Christine Godfrey
Head of Department of Health Sciences & Professor of Health Economics, University of York, York, UK.

Ken Warner
Dean, School of Public Health, University of Michigan; Avedis Donabedian Distinguished University Professor of Public Health; Director, University of Michigan Tobacco Research Network, Ann Arbor, USA.

Trevor Woollery
National Centre for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, USA.

Ayda Yurekli
Senior Economic Advisor, World Health Organization, Tobacco Free Initiative, Geneva, Switzerland.

Policy

Tom Houston, Chair
Director, OhioHealth Nicotine Dependence Program at McConnell Heart Health Center, Columbus, Ohio, USA.

Peter Anderson
Independent Consultant on Public Health, Spain.

Mike Cummings
Chair, Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, USA.

Joe Gitchell
Vice President, Marketing Strategy, Pinney Associates Inc., Bethesda, USA.

Natasha Herrera
Smoking Cessation Clinic and Research, Centro Médico Docente la Trinidad, Venezuela.

Tai Hing Lam
Sir Robert Kotewall Professor in Public Health, School of Public Health and Department of Community Medicine, The University of Hong Kong, Hong Kong, China.

Ann McNeill
Professor of Addictions, UK Centre for Tobacco Control Studies, National Addiction Centre, Institute of Psychiatry, King's College London, UK.

David Sweanor
Adjunct Professor of Law, University of Ottawa, Ottawa, Canada.

Safety

Neal Benowitz, Chair
Professor of Medicine, Psychiatry and Biopharmaceutical Sciences; Chief, Division of Clinical Pharmacology, University of California at San Francisco, USA.

Carolyn Dresler
Branch Chief, Tobacco Prevention and Cessation Program, Arkansas Department of Health, Little Rock, USA.

Steve S Hecht
Director, Carcinogenesis and Chemoprevention Program, University of Minnesota Cancer Center, Minneapolis, USA.

John Hughes
Professor of Psychiatry, Psychology and Family Practice, Department of Psychiatry, University of Vermont, Burlington, USA.

Anne M Joseph
Department of Medicine, VA Medical Center, Minneapolis, USA.

Jacques Le Houezec
Freelance consultant, Rennes, France; Special Lecturer, UK Centre for Tobacco Control Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.

Cheryl Oncken
Associate Professor of Medicine and Obstetrics and Gynecology, University of Connecticut School of Medicine, Farmington, CT, USA.

Maxine Stitzer
Professor, Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, USA.

Editorial Board

Maxine Stitzer, Chair
Professor, Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, USA.

Jack Henningfield, Deputy Chair
Vice President, Research and Health Policy, Pinney Associates Inc., Bethesda, USA.

Paul Aveyard
UK Centre for Tobacco Control Studies, University of Birmingham, Birmingham,UK.

Karl Fagerström
Fagerström Consulting, Helsingborg, Sweden.

Jonathan Foulds
Professor of Public Health Sciences, Penn State University, College of Medicine
Hershey, Pennsylvania, USA.

Nigel Gray
European Institute of Oncology, Milan, Italy.

Peter Hajek
Professor of Clinical Psychology, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary, University of London, London, UK.

Yumiko Mochizuki-Kobayashi
National Institute of Public Health, Tokyo, Japan.

Montezuma Ferreira Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil.

Robyn Richmond
Professor of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.

Saul Shiffman
Research Professor of Psychology, Psychiatry, and Pharmaceutical Sciences, Department of Psychology, University of Pittsburgh, Pittsburgh, USA.

Phillip Tønnesen
Chair, Department of Pulmonary Medicine, Gentofte University Hospital, Copenhagen, Denmark.

Robert West
Professor of Health Psychology, Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, London, UK.

Translation advisors

Arabic, Kamel Abdennbi
Cardiologist & Head, Department of Cardiac Rehabiliation Center, URC Bellan, Paris, France.

Chinese, Dan Xiao
Director, Department of Epidemiology, Beijing Institute of Respiratory Medicine & Professor, WHO Collaborating Center for Tobacco or Health, Beijing, China.

Czech, Eva Kralikova, Kamila Zvolska & Nikol Mladkova
Tobacco Dependence Treatment Centre, 3rd Medical Department, 1st Faculty of
Medicine and General University Hospital, Charles University, Prague, Czech
Republic.

French, Jacques Le Houezec
Freelance consultant, Rennes, France; and Special Lecturer, UK Centre for Tobacco Control Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.

German, Anil Batra1 & Peter Lindinger2
1. Professor and Deputy Director, University Hospital of Tuebingen, Department of Psychiatry and Psychotherapy, Tuebingen, Germany.
2. Freelance consultant, WHO Collaborating Centre on Tobacco Control, German Cancer Research Center, Heidelberg, Germany.

Italian, Giacomo Mangiaracina
Professor, Department of Public Health Sciences, La Sapienza University; Editor, Tabaccologia, Italian Scientific Review; Chief, Tobacco Unit, Italian Cancer League, Rome, Italy.

Japanese, Masakazu Nakamura
Director, Department of Health Promotion and Education, Osaka Center for Cancer and Cardiovascular Disease Prevention, Osaka, Japan.

Portuguese, Montezuma Pimenta Ferreira
Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil.

Russian, Alex Prokhorov
Professor and Director, Tobacco Outreach Education Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Spanish, Javier Saimovici
Internal Medicine Department and Tobacco Control Program, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.

Technical services

bwa-design.
The website was designed and developed by bwa-design, a multi-media design and communications agency which specialises in work for the social, environmental and public sectors.

Anne Hendrie (Editor)
Medical Writer & Technical Editor, Oswestry, UK.

The views expressed in Treatobacco.net are those of its authors and contributors alone, and do not represent the views of the Society for Research on Nicotine and Tobacco.